tanshinone has been researched along with Hypoxia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Y; Du, X; Gao, M; Hou, Y; Li, Z; Tian, Z; Wang, J; Xu, J | 1 |
| Chen, X; Dong, P; Jiang, TT; Li, JM; Li, XQ; Liu, YY; Wu, SH; Wu, XJ; Yan, Y; Zhu, JJ | 1 |
| Liu, Q; Liu, Y; Wang, D; Wang, Y; Yan, X; Zhang, T; Zhao, Z; Zhong, G | 1 |
| Chang, Y; Chen, L; Guo, QH; Guo, YJ; Ji, ES; Wang, N; Zhao, YS | 1 |
| Jiang, W; Liu, BL; Liu, J; Qi, LW; Wang, F; Zhao, YP; Zhou, W | 1 |
| Fan, R; Gao, W; Guo, Y; Mu, S; Qin, G; Sun, Y; Wang, B; Wu, L; Xu, Z; Zhang, Z | 1 |
| Dong, H; Dong, M; Li, Z; Liu, M; Liu, Y; Luo, Y; Niu, W; Wei, M; Yan, Z; Zhao, P; Zheng, L | 1 |
| Li, JX; Miao, ZH; Wang, Y; Wang, YQ | 1 |
| Dong, MQ; Gao, YQ; Li, ZC; Liu, LL; Liu, ML; Luo, Y; Wang, J; Xu, DQ; Xu, M; Zhang, B; Zhao, PT | 1 |
| Feng, J; Li, CH; Liu, HL; Lou, JN; Peng, L; Ye, LY; Zhang, WJ; Zhou, R | 1 |
| Bi, Z; Cai, B; Lu, Y; Shan, H; Yang, L; Yin, L; Zhang, B; Zhang, L | 1 |
| Chan, WY; Chik, KW; Fok, TF; Fung, KP; Gu, GJ; Li, K; Ng, HK; Ng, PC; Wang, CC; Woo, KS; Xia, WJ; Yang, M | 1 |
| Fujimoto, K; Hirai, K; Kawaguchi, K; Ogawa, M; Takeo, S; Tanonaka, K; Yagi, A | 1 |
13 other study(ies) available for tanshinone and Hypoxia
| Article | Year |
|---|---|
Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate/HIF-1α/IL-1β axis.
Topics: Animals; Atherosclerosis; Hypoxia; Interleukin-1beta; Mice; Molecular Docking Simulation; Plaque, Atherosclerotic; Succinates; Succinic Acid | 2023 |
Tanshinone IIA Suppresses Hypoxia-induced Apoptosis in Medial Vestibular Nucleus Cells
Topics: Abietanes; Apoptosis; Humans; Hypoxia; Vestibular Nuclei | 2020 |
Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury.
Topics: Abietanes; Animals; Apoptosis; Cell Line; Cell Movement; Cell Survival; Cells, Cultured; Chemokines; Hypoxia; L-Lactate Dehydrogenase; Macrophages, Peritoneal; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Rats; RNA, Messenger; Saponins; Triterpenes | 2017 |
Tanshinone IIA protects against chronic intermittent hypoxia-induced myocardial injury via activating the endothelin 1 pathway.
Topics: Abietanes; Animals; Apoptosis; Blood Pressure; Cardiotonic Agents; Chronic Disease; Electrocardiography; Endothelin-1; Heart Function Tests; Hemodynamics; Hypoxia; Male; Myocardium; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type III; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Systole | 2017 |
A mitochondrion-targeting tanshinone IIA derivative attenuates myocardial hypoxia reoxygenation injury through a SDH-dependent antioxidant mechanism.
Topics: Abietanes; Animals; Antioxidants; Cells, Cultured; Hypoxia; Mitochondria; Myocardial Ischemia; Rats; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; Succinate Dehydrogenase | 2019 |
Tanshinone IIA pretreatment protects free flaps against hypoxic injury by upregulating stem cell-related biomarkers in epithelial skin cells.
Topics: Abietanes; Animals; beta Catenin; Biomarkers; Cell Line, Tumor; Epithelial Cells; Free Tissue Flaps; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hypoxia; Male; Mice; Mice, Inbred BALB C; Phosphorylation; Signal Transduction; Skin; Skin Transplantation; Stem Cells; Up-Regulation; Vascular Endothelial Growth Factor A | 2014 |
Tanshinone IIA attenuates hypoxic pulmonary hypertension via modulating KV currents.
Topics: Abietanes; Animals; Blotting, Western; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Pulmonary Artery; Rats; Reverse Transcriptase Polymerase Chain Reaction | 2015 |
Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Aorta; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Chickens; Chorioallantoic Membrane; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; STAT3 Transcription Factor; Tumor Cells, Cultured; Tyrosine | 2015 |
Tanshinone IIA modulates pulmonary vascular response to agonist and hypoxia primarily via inhibiting Ca2+ influx and release in normal and hypoxic pulmonary hypertension rats.
Topics: Abietanes; Animals; Calcium; Carbon Monoxide; Endothelium, Vascular; Extracellular Space; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Intracellular Space; Male; Nitric Oxide; Phenanthrenes; Phenylephrine; Potassium; Potassium Channel Blockers; Prostaglandins; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasoconstriction | 2010 |
Tanshinone IIA protects the human blood-brain barrier model from leukocyte-associated hypoxia-reoxygenation injury.
Topics: Abietanes; Blood-Brain Barrier; Culture Media, Conditioned; Electric Impedance; Endothelial Cells; Humans; Hypoxia; Leukocytes; Oxygen; Permeability; Phenanthrenes; Reperfusion Injury | 2010 |
Tanshinone IIA prevented brain iron dyshomeostasis in cerebral ischemic rats.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Brain Ischemia; Cation Transport Proteins; Hypoxia; Iron; Male; Membrane Proteins; Rats; Rats, Wistar; Receptors, Transferrin | 2011 |
Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Body Temperature; Brain; Brain Diseases; Cell Survival; Dose-Response Relationship, Drug; Free Radicals; Hypoxia; Hypoxia-Ischemia, Brain; In Vitro Techniques; Ischemia; Mitochondria; Models, Chemical; Neurons; Organ Size; Oxygen; Phenanthrenes; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |
Beneficial effect of tan-shen, an extract from the root of Salvia, on post-hypoxic recovery of cardiac contractile force.
Topics: Abietanes; Adenosine Triphosphate; Animals; Calcium; Cardiovascular Agents; Creatine Kinase; Hypoxia; Male; Myocardial Contraction; Myocardial Reperfusion; Phenanthrenes; Phosphates; Rats; Rats, Inbred Strains | 1990 |